Funding Opportunities

New Funding Opportunities

See the Events page for webinars and technical assistance videocasts on applying to certain Funding Opportunity Announcements.

Notice HEALthy Brain and Child Development Study (HEALthy BCD) (Collaborative R34 Clinical Trial Not Allowed)
Notice Number RFA-DA-19-029
Post Date December 21, 2018
Expiration Date March 26, 2019
Notice HEALthy Brain and Child Development Study (HEALthy BCD) (R34 Clinical Trial Not Allowed)
Notice Number RFA-DA-19-036
Post Date December 21, 2018
Expiration Date March 26, 2019
Notice Antenatal Opioid Exposure Longitudinal Study Consortium (PL1 Clinical Trials Not Allowed)
Notice Number RFA-HD-19-025
Post Date December 10, 2018
Expiration Date March 30, 2019
Notice Justice Community Opioid Innovation Network (JCOIN) Coordination and Translation Center (U2C Clinical Trial Optional)
Notice Number RFA-DA-19-024
Post Date December 10, 2018
Expiration Date February 28, 2019
Notice Justice Community Opioid Innovation Network (JCOIN) Clinical Research Centers (UG1 Clinical Trial Optional)
Notice Number RFA-DA-19-025
Post Date December 10, 2018
Expiration Date February 28, 2019
Notice Translational Devices to Treat Pain (UG3/UH3 Clinical Trial Optional)
Notice Number RFA-NS-19-016
Post Date December 10, 2018
Expiration Date February 22, 2021
Notice Translational Devices to Treat Pain (U44 Clinical Trial Optional)
Notice Number RFA-NS-19-017
Post Date December 10, 2018
Expiration Date February 22, 2021
Notice Clinical Devices to Treat Pain (UH3 Clinical Trial Optional)
Notice Number RFA-NS-19-018
Post Date December 10, 2018
Expiration Date February 22, 2021
Notice Optimization of Non-addictive Therapies [Small Molecules and Biologics] to Treat Pain - (U44 Clinical Trial Not Allowed)
Notice Number RFA-NS-19-020
Post Date December 10, 2018
Expiration Date March 7, 2019
Notice Translational Development of Devices to Treat Pain (U18 Clinical Trial Not Allowed)
Notice Number RFA-EB-18-003
Post Date December 10, 2018
Expiration Date February 23, 2021
Notice Back Pain Consortium (BACPAC) Research Program: Mechanistic Research Centers (U19) (Clinical Trial Optional)
Notice Number RFA-AR-19-026
Post Date December 10, 2018
Expiration Date March 21, 2019
Notice Back Pain Consortium (BACPAC) Research Program Data Integration, Algorithm Development and Operations Management Center (U24) (Clinical Trial Not Allowed)
Notice Number RFA-AR-19-027
Post Date December 10, 2018
Expiration Date March 21, 2019
Notice Back Pain Consortium (BACPAC) Research Program Technology Research Sites (UH2/UH3) (Clinical Trial Optional)
Notice Number RFA-AR-19-028
Post Date December 10, 2018
Expiration Date March 21, 2019
Notice Back Pain Consortium (BACPAC) Research Program: Phase 2 Clinical Trials (UG3/UH3) (Clinical Trial Required)
Notice Number RFA-AR-19-029
Post Date December 10, 2018
Expiration Date February 27, 2019
Notice Integrated Approach to Pain and Opioid Use in Hemodialysis Patients: The Hemodialysis Opioid Prescription Effort (HOPE) Consortium - Clinical Centers (U01 Clinical Trial Required)
Notice Number RFA-DK-18-030
Post Date December 10, 2018
Expiration Date March 28, 2019
Notice Integrated Approach to Pain and Opioid Use in Hemodialysis Patients: The Hemodialysis Opioid Prescription Effort (HOPE) Consortium - Scientific and Data Research Center (U01 Clinical Trial Required)
Notice Number RFA-DK-18-031
Post Date December 10, 2018
Expiration Date March 28, 2019
Notice Coordinating Center to Support NIDA Preventing Opioid Use Disorder in Older Adolescents and Young Adults (ages 16–30) Initiative (U24 Clinical Trial Not Allowed)
Notice Number RFA-DA-19-034
Post Date December 10, 2018
Expiration Date March 14, 2019
Notice Preventing Opioid Use Disorder in Older Adolescents and Young Adults (ages 16–30) (UG3/UH3 Clinical Trial Required)
Notice Number RFA-DA-19-035
Post Date December 10, 2018
Expiration Date March 14, 2019
Notice Pragmatic Randomized Controlled Trial of Acupuncture for Management of Chronic Low Back Pain in Older Adults (UG3/UH3 Clinical Trial Required)
Notice Number RFA-AT-19-005
Post Date December 10, 2018
Expiration Date March 16, 2019
Notice Justice Community Opioid Innovation Network (JCOIN) Methodology and Advanced Analytics Resource Center (U2C Clinical Trial Not Allowed)
Notice Number RFA-DA-19-023
Post Date December 10, 2018
Expiration Date February 28, 2019
Notice Tissue Chips to Model Nociception, Addiction, and Overdose (UG3/UH3 Clinical Trial Not Allowed)
Notice Number RFA-TR-19-003
Post Date December 10, 2018
Expiration Date March 1, 2019
Notice Biofabricated 3D Tissue Models of Nociception, Opioid Use Disorder and Overdose for Drug Screening (UH2/UH3 – Clinical Trial Not Allowed)
Notice Number RFA-TR-19-005
Post Date December 10, 2018
Expiration Date March 1, 2019
Notice America’s Startups and Small Businesses Build Technologies to Stop the Opioid Crisis (R43/R44 - Clinical Trial Optional)
Notice Number RFA-DA-19-019
Post Date December 10, 2018
Expiration Date September 9, 2021
Notice America’s Startups and Small Businesses Build Technologies to Stop the Opioid Crisis (R41/R42 - Clinical Trial Optional)
Notice Number RFA-DA-19-020
Post Date December 10, 2018
Expiration Date September 9, 2021
Notice Sleep and Circadian-Dependent Mechanisms Contributing to Opiate Use Disorder (OUD) and Response to Medication Assisted Treatment (MAT) (R01 - Clinical Trial Not Allowed)
Notice Number RFA-HL-19-028
Post Date December 10, 2018
Expiration Date February 28, 2019
Notice Sleep and Circadian-Dependent Mechanisms Contributing to Opiate Use Disorder (OUD) and Response to Medication Assisted Treatment (MAT) (U01 Clinical Trial Optional)
Notice Number RFA-HL-19-029
Post Date December 10, 2018
Expiration Date February 28, 2019
Notice Effectiveness Trials to Optimize, Implement, Scale, and Sustain the Collaborative Care Model for Individuals with Opioid Use Disorders and Mental Health Conditions (U01 Clinical Trials Required)
Notice Number RFA-MH-19-525
Post Date December 10, 2018
Expiration Date April 2, 2019
Notice Limited Competition: Behavioral Research to Improve MAT: Ancillary Studies to Enhance Behavioral or Social Interventions to Improve Adherence to Medication Assisted Treatment for Opioid Use Disorders (R01, Clinical Trials Optional)
Notice Number RFA-AT-19-007
Post Date December 10, 2018
Expiration Date March 16, 2019
Notice Announcement of the NCATS ASPIRE Design Challenges to Develop Innovative and Catalytic Approaches Towards Solving the Opioid Crisis
Notice Number NOT-TR-18-031
Post Date December 10, 2018
Expiration Date N/A
Notice Notice of Interest in Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Applications Directed at Enhanced Pain Management and Improved Treatments for Opioid Misuse and Addiction
Notice Number NOT-NS-19-014
Post Date December 10, 2018
Expiration Date N/A
Notice Request for Administrative Supplements to Existing Grants to Accelerate Research on Preventing Opioid Use Disorder in Older Adolescents and Young Adults (ages 16–30)
Notice Number NOT-DA-19-003
Post Date December 10, 2018
Expiration Date N/A
Notice Optimization of Non-addictive Therapies [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Not Allowed)
Notice Number RFA-NS-19-010
Post Date November 5, 2018
Expiration Date March 7, 2019
Notice Analytical and/or Clinical Validation of a Candidate Biomarker for Pain (R61/R33 Clinical Trial Optional)
Notice Number RFA-NS-18-046
Post Date September 19, 2018
Expiration Date March 13, 2020
Notice Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed)
Notice Number RFA-NS-18-043
Post Date September 19, 2018
Expiration Date November 13, 2019
Notice Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R21 Clinical Trial Not Allowed)
Notice Number RFA-NS-18-042
Post Date September 19, 2018
Expiration Date November 13, 2019
Notice Discovery of Biomarkers, Biomarker Signatures, and Endpoints for Pain (R61/R33 Clinical Trial Optional)
Notice Number RFA-NS-18-041
Post Date August 2, 2018
Expiration Date March 13, 2020
Notice Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose (UG3/UH3) (Clinical Trial Optional)
Notice Number RFA-DA-19-002
Post Date December 14, 2017
Expiration Date January 2, 2020
Notice NIDA Translational Avant-Garde Award for Development of Medication to Treat Substance Use Disorders (UG3/UH3 Clinical Trial Optional)
ID Number RFA-DA-18-020
Post Date December 6, 2017
Expiration Date September 8, 2020
Notice Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)
Notice Number PAR-18-219
Post Date November 21, 2017
Expiration Date July 26, 2019
Notice Strategic Alliances for Medications Development to Treat Substance Use Disorders (R01 Clinical Trial Optional)
Notice Number PAR-18-218
Post Date November 21, 2017
Expiration Date July 26, 2019

Funded Projects

Opioid Addiction and Overdose Medications

Project Title Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose (UG3/UH3)
Awardees
Funding Opportunity Announcement RFA-DA-19-002
Summary Support the discovery and development of medications to prevent and treat opioid use disorders (OUD) and overdose.
Project Title Prescription Drug Abuse (R01 Clinical Trial Optional)
Awardee McLean Hospital
Funding Opportunity Announcement PA-18-058
Summary  Reduce the side effect and abuse liability profiles of opioid drugs.
Project Title Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)
Awardee Biomedical Research Institute of New Mexico
Funding Opportunity Announcement PAR-18-219
Summary Synthesize and test novel drug candidates for progression to new human anti-addiction pharmacotherapies for substance use disorders.
Project Type New Projects within Current Research
Awardee Virginia Commonwealth University
Summary This supplement supports research to expand therapeutic options for addiction, overdose prevention and reversal.

Implementation Science for Preventing and Treating Addiction

Addiction Prevention and Treatment

Project Title Behavioral Interventions for Prevention of Opioid Use Disorder or Adjunct to Medication Assisted Treatment-SAMHSA Opioid STR Grants (R21/R33)
Awardee University of Washington
Funding Opportunity Announcement RFA-AT-18-001
Summary Examine the impact of interventions such as mindfulness meditation, cognitive behavioral therapy, or multi-disciplinary rehabilitation for primary or secondary prevention for opioid use disorder (OUD) or as an adjunct to medication assisted treatment (MAT) of OUD.
Project Title Clinical Trials or Observational Studies of Behavioral Interventions for Prevention of Opioid Use Disorder or Adjunct to Medication Assisted Treatment-SAMHSA Opioid STR Grants (R21/R33)
Awardees
Funding Opportunity Announcement RFA-AT-18-002
Summary Test approaches using behavioral interventions for primary or secondary prevention of opioid use disorder (OUD) or as an adjunct to medication assisted treatment for OUD.
Project Type New Projects within Current Research
Awardees
Summary These supplements support research to develop therapies to treat opioid use disorder and prevent and reverse overdose.

Preclinical Research on Pain

Project Type New Projects within Current Research
Awardees
Summary These supplements support research to accelerate the discovery and preclinical development of new medication and device treatments for pain.

Clinical Trials on Pain Management

Project Type New Projects within Current Research
Awardees
Summary These supplements support research to understand the biological underpinnings of chronic pain, identify new biomarkers for pain, and create a clinical trials network for testing new pain therapies.

Improving Outcomes in Infants and Children Exposed to Opioids

Project Type New Projects within Current Research
Awardees
Summary These supplements support research to improve short- and long-term developmental outcomes in children exposed to opioids.

This page last reviewed on February 15, 2019